Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.1.29

Expression of Osteopontin in Non-small Cell Lung Cancer and Correlative Relation with Microvascular Density  

Yu, Ting-Ting (Department of Chemotherapy, Tumor Hospital Affiliated to Xinjiang Medical University)
Han, Zhi-Gang (Department of Chemotherapy, Tumor Hospital Affiliated to Xinjiang Medical University)
Shan, Li (Department of Chemotherapy, Tumor Hospital Affiliated to Xinjiang Medical University)
Tao, Jie (Department of Chemotherapy, Tumor Hospital Affiliated to Xinjiang Medical University)
Zhang, Tao (Department of Chemotherapy, Tumor Hospital Affiliated to Xinjiang Medical University)
Yuan, Shuai-Fei (Department of Chemotherapy, Tumor Hospital Affiliated to Xinjiang Medical University)
Shen, Hong-Li (Department of Chemotherapy, Tumor Hospital Affiliated to Xinjiang Medical University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.1, 2014 , pp. 29-32 More about this Journal
Abstract
Background and Objective: Lung cancer is one of the malignant diseases which most seriously threat humansurvival and development. This study aimed to assess osteopontin (OPN) expression in non-small cell lung cancer (NSCLC) and any relationship with clinicopathological features. Methods: Immunohistochemistry was used to determine OPN expression and microvascular density (MVD) in 120 cases of NSCLC also undergoing clinical assessment. Results: Moderately positive expression of OPN was found in 34.6% (41/120) and strong expression in 47.5% (57/120) of the NSCLCs; OPN expression in carcinomas was higher than in pericarcinoma tissues (P<0.05). While no obvious association was observed with NSCLC patient age, gender, maximum diameter of the tumor and pathological type, OPN expression was more commonly detected in poorly differentiated carcinoma tissue and lymph node metastasis as well as at advanced clinical stage (P<0.05); OPN expression in cancer tissue was positively correlated with MVD (r = 0.839, P = 0.000). Conclusion: OPN plays an important role in promoting tumor angiogenesis and progress of NSCLCs and has the possibility to become the new target for therapy.
Keywords
Lung cancer; osteopontin; microvascular density; immunohistochemy;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Lund SA, Wilson CL, Raines EW, et al (2013). Osteopontin mediates macrophage chemotaxis via ${\alpha}$4 and ${\alpha}$9 integrins and survival via the ${\alpha}$4 integrin. J Cell Biochem, 114, 1194-202.   DOI   ScienceOn
2 Maeda R, Ishii G, Ito M, et al (2012). Number of circulating endothelial progenitor cells and intratumoral microvessel density in non-small cell lung cancer patients: differences in angiogenic status between adenocarcinoma histologic subtypes. J Thorac Oncol, 7, 503-11.   DOI   ScienceOn
3 Matusan-Ilijas K, Damante G, Fabbro D, et al (2011). Osteopontin expression correlates with nuclear factor-${\kappa}$B activation and apoptosis down regulation in clear cell renal cell carcinoma. Pathol Res Pract, 207, 104-10.   DOI   ScienceOn
4 Qin LF, Wang WC, Fang H, et al (2013). Expression of NF-${\kappa}$B and osteopontin of synovial fluid of patients with knee osteoarthritis. Asian Pac J Trop Med, 6, 379-382.   DOI   ScienceOn
5 Qiu ZB, Xu H, Duan C, Xin C (2012). Osteopontin is required for angiotensin II-induced migration of vascular smooth muscle cells. Pharmazie, 67, 553-8.
6 Rao G, Wang H, Li B, et al (2013). Reciprocal interactions between tumor-associated macrophages and CD44-positive cancer cells via osteopontin/CD44 promote tumorigenicity in colorectal cancer. Clin Cancer Res, 19, 785-97.   DOI   ScienceOn
7 Elli M, Dagdemir A, Bozkurt C, et al (2012). Serum osteopontin and CD44 levels in lymphoreticular malignancies in children. Bratisl Lek Listy, 113, 534-8.
8 Hartung F, Weber GF (2013). RNA blood levels of osteopontin splice variants are cancer markers. Springer Plus, 2, 110.   DOI
9 Huan JL, Xing L, Qin XJ, et al (2012). Expression and clinical significance of osteopontin in calcified breast tissue. Asian Pac J Cancer Prev, 13, 5219-23.   과학기술학회마을   DOI   ScienceOn
10 Huang J, Pan C, Hu H, Zheng S, Ding L (2012). Osteopontin enhanced hepatic metastasis of colorectal cancer cells. PLoS One, 7, e47901.   DOI
11 Ito S, Miyahara R, Takahashi R, et al (2009). Stromal aminopeptidase N expression: correlation with angiogenesis in non-small-cell lung cancer. Gen Thorac Cardiovasc Surg, 57, 591-8.   DOI
12 Luo X, Ruhland MK, Pazolli E, Lind AC, Stewart SA (2011). Osteopontin stimulates preneoplastic cellular proliferation through activation of the MAPK pathway. Mol Cancer Res, 9, 1018-29.   DOI
13 Samitas K, Zervas E, Xanthou G, Vily P, Gaga M (2013). Osteopontin is increased in the bronchoalveolar lavage fluid and bronchial tissue of smoking asthmatics. Cytokine, 61, 713-5.   DOI   ScienceOn
14 Sun BS, You J, Li Y, Zhang ZF, Wang CL (2013).Osteopontin knockdown suppresses non-small cell lung cancer cell invasion and metastasis. Chin Med J (Engl), 126, 1683-8.
15 Tsai WC, Tsai WC, Lee HS, et al (2012). Association between Osteopontin and EGFR Expression with Clinicopathological Parameters in Hepatocellular Carcinoma. Chin J Physiol, 55, 412-20.   DOI   ScienceOn